A Universidade Federal de São Paulo é uma instituição de ensino superior pública brasileira localizada no estado de São Paulo, sendo uma das três universidades federais do estado, ao lado da Universidade Federal de São Carlos e a Universidade Federal do ABC.

During the past decade, Universidade Federal de São Paulo conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 18 clinical trials were completed, i.e. on average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 8 clinical trials were completed. i.e. 38.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universidade Federal de São Paulo" #1 sponsor was "Federal University of São Paulo" with 48 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Hospital Israelita Albert Einstein" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Apellis Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universidade Federal de São Paulo" #1 collaborator was "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 9 trials as a collaborator, "Federal University of São Paulo" with 3 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator and "Hospital do Coracao" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Universidade Federal de São Paulo" are "Obesity" (3 trials), "Obstructive Sleep Apnea" (3 trials), "COVID-19" (2 trials), "Dravet Syndrome (DS)" (2 trials) and "Fibromyalgia" (2 trials). Many other conditions were trialed in "Universidade Federal de São Paulo" in a lesser frequency.

Most popular intervention types in "Universidade Federal de São Paulo" are "Drug" (65 trials), "Other" (25 trials), "Device" (16 trials), "Procedure" (9 trials) and "Behavioral" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Soticlestat" (3 trials), "APL-2" (2 trials), "Bupivacaine" (2 trials) and "LASER" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universidade Federal de São Paulo" are 91 trials for "All" genders, 22 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Universidade Federal de São Paulo". 1 are not yet recruiting, 15 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Universidade Federal de São Paulo, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Universidade Federal de São Paulo, 4 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 33 trials that are defined as “Not Applicable".

Universidade Federal de São Paulo has several departments that took part in Clinical trials: "Departamento de Psicobiologia" - 2 trials, "Ambulatório de Ginecologia Endócrina" - 2 trials